Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and TACE inhibitors
申请人:Wyeth Holdings Corporation
公开号:US06825354B2
公开(公告)日:2004-11-30
Compounds of the formula
are useful in treating disease conditions mediated by TNF-&agr;, such as rheumatoid arthritis, osteoarthritis, sepsis, AIDS, ulcerative colitis, multiple sclerosis, Crohn's disease and degenerative cartilage loss.